Duke Radiology Grand Rounds Lectures are conducted on Thursdays at 7:30 a.m.- 8:30 a.m. in Room 2002 Duke North. The mission for Radiology Grand Rounds is to provide an educational format which has a broad appeal to faculty and trainees. If you have any further questions regarding Radiology Grand Rounds, please contact Debbie Griffin at 919-684-7228.
Personalized Breast Imaging
What is the future of Breast Cancer Screening?
Leading and Succeeding in an Age of Disruption
Today’s complex challenges require collaboration and increased focus on sense-making. This session will highlight key trends in leadership and culture building, drawing on Sanyin’s experiences in working with leaders from industry, sports, tech, and military. A theme through Sanyin’s work is convening interdisciplinary, diverse think tank gatherings towards defining complex problems and implementing new approaches for solving them. Learn from her experience as a leadership coach and from the smart practical field guide contained in her award-winning book titled, The Launch Book: Motivational Stories to Launch Your Idea, Business or Next Career.
RadHacks: Leveraging Readily Available IT Solutions for Radiologists
The practice of Radiology is dependent on effective system utilization. Implementation is challenging due to variable system complexities, ongoing change, and a spectrum of organizational demands. Furthermore, there exists heterogeneity among divisional units and individual radiologists depending on a multitude of factors. The presentation will highlight available software and hardware tools that can be leveraged to maximize radiologist efficiency in different practice settings within the Duke Department of Radiology and beyond. We will discuss how tools can be synergistically employed to curtail inefficiency and increase value. Finally, we will examine how solutions can be adapted to evolving systems and radiologists with different technological backgrounds.
Updates in Nuclear Imaging
Implementation and execution of precision medicine techniques continues to evolve. New and improved biomarkers along with genetic testing guide clinicians in selecting optimal patient-specific therapies. Nuclear and molecular imaging play a crucial role in establishing accurate diagnosis and prognosis as well as identifying viable therapeutic options. Recent advancements in oncologic molecular imaging techniques will allow diagnosis of micrometastatic disease that was previously undetectable. The FDA has recently approved multiple new radiotracers for clinical imaging. During this presentation, we will discuss the various diagnostic and therapeutic applications of these novel oncologic radiotracers.
Cancer Screening, Breast Surgery, and the Hippocratic Oath: a Cautionary Tale
Over 62,000 women in the United States will be diagnosed with ductal carcinoma in situ (DCIS) this year alone, almost all of these diagnoses made in completely asymptomatic individuals on screening mammography. It has been estimated that without treatment, only 20-30% of DCIS progress to invasive cancer in the long term. In those women who don’t progress, treatment can only result in harm without offering any benefit. The central role of breast imaging as a cause and as a promising research tool is a topic of active investigation as researchers seek to mitigate breast cancer overtreatment through a highly multidisciplinary approach.
Morbidity and Mortality (Private Conference)
Breast Imaging and Beyond: the radiologist's evolving role in patient-centered care
Patient-centered care (PCC) is a care model in which patients and families partner with providers and care teams, collaborating in shared decision-making processes to optimize patient care and satisfaction. While breast imaging has been the traditional radiology leader in this approach to care, the current era of value-based care is prompting radiology departments to extend their focus on patient satisfaction to other areas of radiology, expanding the radiologist’s role in patient communication, education and shared decision making. This presentation will review current breast imaging research and practices for optimizing patient care, and describe recent proposals for expanding these practices to other areas of radiology, including adapting for diversity, targeted patient education, and furthering radiologist-patient communication, with a discussion of the need for radiologist resiliency during these transitions.
Update on Medical 3D Printing, including CPT codes
Medical 3D printing has been in use for over 20 years, but only over the past 5 years has it begun to be recognized at society organizations. The Radiological Society of North America (RSNA) created its first Special Interest Group (SIG) on 3D printing, and the group has provided stewardship for anatomic models. Recently, Category III CPT codes were approved for 3D printing; these codes will be active on July 1, 2019. This talk will provide some benchmarks in the field and provide challenges and opportunities for medical practitioners.
Objective Tumor Response for Solid Neoplasms and Computer-Assisted Response Evaluation
Renal cell carcinoma metastases are vascular and anti-angiogenic agents have become first line therapy. Tumor size changes in response to anti-angiogenic therapy are often delayed and underestimate tumor response in patients with metastatic renal cell carcinoma. Objective response to systemic therapy, as measured on computed tomography, determines critical endpoints in patient care; however, there are wide differences in how tumor size and response are assessed in clinical trials versus clinical practice. Computer-assisted response evaluation (CARE) can be used to prevent errors and improve efficiency and communication in assessing objective tumor response in patients with metastatic disease